Haleon PLC (NYSE:HLN)
$ 8.38 -0.08 (-0.95%) Market Cap: 38.26 Bil Enterprise Value: 49.20 Bil PE Ratio: 27.37 PB Ratio: 1.80 GF Score: 27/100

HALEON PLC at UBS European Conference (Virtual) Transcript

Nov 09, 2021 / NTS GMT
Guillaume Delmas
UBS Group AG - Analyst

Hello, everyone, and welcome to this fireside chat. My name is Guillaume Delmas, I have the European food and HPC team here at UBS. So today, we are absolutely delighted to have with us Tobias Hestler, GSK Consumer Healthcare, Chief Financial Officer.

Tobias, thank you very much for taking the time today to answer our questions. Now, we've got half an hour. So for the purpose of today's fireside chat, I was thinking about starting with a focus on GSK Consumer Healthcare organic sales growth prospects before turning my attention to your margin opportunities.

And with that, let's begin.

Questions & Answers

Guillaume Delmas
UBS Group AG - Analyst

So on organic sales growth, you anticipate medium-term category growth of 3% to 4% in oral care, 4% to 5% in VMS, 2% to 3% in OTC; which gives broadly a sales weighted average of around 3%. Now you've clearly stated that your ambition is to grow ahead of the market. So maybe can we start by you shedding some light of the main factors that should drive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot